M&A Deal Summary

Zealand Pharma Acquires Valeritas

On February 10, 2020, Zealand Pharma acquired medical products company Valeritas for 23M USD

Acquisition Highlights
  • This is Zealand Pharma’s 1st transaction in the Medical Products sector.
  • This is Zealand Pharma’s largest (disclosed) transaction.
  • This is Zealand Pharma’s 1st transaction in the United States.
  • This is Zealand Pharma’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2020-02-10
Target Valeritas
Sector Medical Products
Buyer(s) Zealand Pharma
Deal Type Special Situations/Distressed
Deal Value 23M USD
Advisor(s) Lincoln International (Financial)
DLA Piper
PwC Law (Legal)

Target

Valeritas

Bridgewater, New Jersey, United States
Valeritas, Inc. is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas, Inc. designed the first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Zealand Pharma

Soborg, Denmark
Category Company
Founded 1997
Sector Life Science
Employees288
Revenue 343M DKK (2023)
DESCRIPTION

Zealand Pharma is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focuses on specialty gastrointestinal and metabolic diseases. Zealand’s portfolio also includes two clinical license collaborations with Boehringer Ingelheim and a pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand Pharma was founded in 1997 and is headquartered in Soborg, Denmark.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Special Situations/Distressed) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal